Baird Financial Group, Inc.
Source: SEC Form 13F · as of Mar 2026Baird Financial Group, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $226.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$226.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for BeOne Medicines Ltd. (ONC)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ONCBeOne Medicines Ltd. | 349,651 | $103.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 57,589 | $44.5M |
| GILDGILEAD SCIENCES, INC. | 282,089 | $39.3M |
| INCYIncyte Corp. | 186,860 | $17.6M |
| SNYSanofi | 141,110 | $6.8M |
| BBIOBridgeBio Pharma, Inc. | 40,531 | $3.0M |
| INSMINSMED Inc | 17,688 | $2.9M |
| LGNDLigand Pharmaceuticals Incorporated | 12,981 | $2.6M |
| KNSAKiniksa Pharmaceuticals International, plc | 40,249 | $1.9M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 23,839 | $1.3M |
| PCVXVaxcyte, Inc. | 13,788 | $801K |
| ALTAltimmune, Inc. | 237,522 | $732K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 198,540 | $697K |
| EXELEXELIXIS, INC. | 5,783 | $248K |
| MRNAModerna, Inc. | 4,781 | $243K |
| SGMTSagimet Biosciences Inc. | 13,086 | $68K |
| BRNSBarinthus Biotherapeutics plc. | 105,961 | $60K |
| GERNGERON CORP | 11,500 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.